Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2021
Pharma News, 2021
FDA alerts patients and health care professionals about clinical trial results showing an increased risk of death associated with Pepaxto (melphalan flufenamide)
FDA is alerting patients and health care professionals that a clinical trial (OCEAN, Study OP-103) evaluating Pepaxto (melphalan flufenamide) with dexamethasone to treat patients with ...
U.S. FDA allows Lilly's COVID-19 drug to be taken without remdesivir
(Reuters) - The U.
$2.5B Teneobio Deal Complements Amgen's Core and Capabilities
Amgen is snapping up privately-held TeneoBio and its class of biologics dubbed Human Heavy-Chain Antibodies in a deal that could total $2.
Study could lead to blood-based diagnostic test for schizophrenia
Scientists at Sanford Burnham Prebys have discovered how levels of a protein could be used in the future as a blood-based diagnostic aid for schizophrenia.
Lawmakers press FDA for answers about its plans to restart foreign inspections
From March to October of last year, the FDA conducted just three foreign inspections.
AC Immune acquires Parkinson’s disease vaccine candidate
Swiss biopharma company AC Immune has announced its acquisition of a Parkinson’s disease vaccine candidate, developed by Affiris.
Merck's Keytruda scores first-in-class nod in early triple-negative breast cancer despite FDA's prior reluctance
The FDA had reservations about Merck & Co.
BioNTech to develop a mRNA-based malaria vaccine
BioNTech has announced that the launch of a new project aimed a developing a ‘highly effective’ mRNA-based malaria vaccine candidate.
Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity
TARRYTOWN, N.
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 July 2021 Share
Two new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended two medicines for approval at its July 2021 meeting.
INmune Bio, Inc. Announces Design of Upcoming Phase 2 Alzheimer’s Disease Clinical Trial and New Phase 1b AD Biomarker Data
Boca Raton, FL, July 26, 2021 (GLOBE NEWSWIRE) -- INmune Bio, Inc.
A Rationally Designed Therapeutic Vaccine for Herpes
There is a pandemic raging across the world – and it has nothing to do with a coronavirus.
27
28
29
30
31
32
33
34
35
